These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 16344430
21. Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer. Nader F. N Engl J Med; 2003 Oct 02; 349(14):1385-7; author reply 1385-7. PubMed ID: 14526767 [No Abstract] [Full Text] [Related]
22. [Thrombosis prophylaxis in knee arthroscopy. A survey of a Cochrane review]. Jørgensen LN, Lykke J. Ugeskr Laeger; 2008 Nov 03; 170(45):3646-9. PubMed ID: 18986613 [No Abstract] [Full Text] [Related]
23. [Heparin and cancer]. Lykke J. Ugeskr Laeger; 2006 Dec 11; 168(50):4397-401. PubMed ID: 17217864 [Abstract] [Full Text] [Related]
24. Venous thromboembolism and cancer: prevention and therapy. Lee AY. Vnitr Lek; 2006 Mar 11; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461 [Abstract] [Full Text] [Related]
25. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival. Nishioka J, Goodin S. J Oncol Pharm Pract; 2007 Jun 11; 13(2):85-97. PubMed ID: 17873108 [Abstract] [Full Text] [Related]
26. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism. Prandoni P. J Support Oncol; 2006 Mar 11; 4(3):127-8. PubMed ID: 16553138 [No Abstract] [Full Text] [Related]
27. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis. Cunningham RS. Semin Oncol; 2006 Apr 11; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457 [Abstract] [Full Text] [Related]
28. Prevention of venous thromboembolism. Pini M, Spyropoulos AC. Semin Thromb Hemost; 2006 Nov 11; 32(8):755-66. PubMed ID: 17171588 [Abstract] [Full Text] [Related]
29. [Prevention of venous thromboembolism in orthopedic surgery and traumatology]. Agnelli G, Cimminiello C. Recenti Prog Med; 2007 Jan 11; 98 Suppl 1():25S-32S. PubMed ID: 17455706 [No Abstract] [Full Text] [Related]
30. Preventing venous thromboembolism in the intensive care unit: A no-brainer? Gould MK. J Crit Care; 2005 Dec 11; 20(4):304-5. PubMed ID: 16310598 [No Abstract] [Full Text] [Related]
31. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care? Burris HA. Semin Oncol; 2006 Apr 11; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456 [Abstract] [Full Text] [Related]
33. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial). Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J, ECHOS Trial Group. Int Angiol; 2006 Dec 11; 25(4):335-42. PubMed ID: 17164738 [Abstract] [Full Text] [Related]
34. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices. Lee AY. Dis Mon; 2005 Dec 11; 51(2-3):150-7. PubMed ID: 15900267 [No Abstract] [Full Text] [Related]
35. Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study. Monreal M, Zacharski L, Jiménez JA, Roncales J, Vilaseca B. J Thromb Haemost; 2004 Aug 11; 2(8):1311-5. PubMed ID: 15304036 [Abstract] [Full Text] [Related]
36. Prevention of venous thromboembolism in surgical patients with breast cancer. Patiar S, Kirwan CC, McDowell G, Bundred NJ, McCollum CN, Byrne GJ. Br J Surg; 2007 Apr 11; 94(4):412-20. PubMed ID: 17380560 [Abstract] [Full Text] [Related]
37. Update on in hospital venous thromboembolism prophylaxis. Bergqvist D. Eur J Vasc Endovasc Surg; 2007 Mar 11; 33(3):343-50. PubMed ID: 17236793 [Abstract] [Full Text] [Related]
38. Routine chemoprophylaxis for travel-associated thrombosis? No. Lubetsky A. Isr Med Assoc J; 2006 Dec 11; 8(12):862-3. PubMed ID: 17214106 [No Abstract] [Full Text] [Related]